Ethosuximide
PubChem CID: 3291
Connections displayed (default: 10).
Loading graph...
| Compound Synonyms | ethosuximide, 77-67-8, Zarontin, Etosuximida, Ethosuxide, Pyknolepsinum, 2-Ethyl-2-methylsuccinimide, Ethosuccimide, Ethosuccinimide, Atysmal, Suxilep, Suxinutin, Etosuximid, Mesentol, Pentinimid, Peptinimid, Petinimid, Petnidan, Succimal, Succimitin, Thetamid, Zaraondan, Zarondan, Zartalin, Asamid, Capitus, Emeside, Ethymal, Etomal, Pemalin, Ronton, Simatin, Suximal, Zarodan, Pemal, Suxin, 3-Ethyl-3-methylpyrrolidine-2,5-dione, Aethosuximide, Piknolepsin, Thilopemal, Epileo Petit MAL, Zarondan-Saft, Ethosuximidum, 3-Ethyl-3-methyl-2,5-pyrrolidinedione, Simatin(E), 3-Methyl-3-ethylsuccinimide, Aethosuccimidum, Etosuximide, 2-Methyl-2-ethylsuccinimide, CI-366, 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, 3-Ethyl-3-methylsuccinimide, Etosuccimide, PM-671, Succinimide, 2-ethyl-2-methyl-, CN-10,395, PM 671, alpha-Ethyl-alpha-methylsuccinimide, alpha-Methyl-alpha-ethylsuccinimide, 3-Methyl-3-ethylpyrrolidine-2,5-dione, N-Ethyl methylsuccinimide, gamma-Methyl-gamma-ethyl-succinimide, C.I. 366, H 940, H-490, Ethosuximidum [INN-Latin], Etosuximida [INN-Spanish], CN-10395, (+-)-2-Ethyl-2-methylsuccinimide, NSC-64013, Cl 366, HSDB 1119, UNII-5SEH9X1D1D, gamma-ethyl-gamma-methyl-succinimide, EINECS 201-048-7, 5SEH9X1D1D, CI 366, NSC 64013, BRN 0117054, CHEBI:4887, DTXSID7023019, NSC64013, MFCD00072123, 3-Ethyl-3-methylpyrroline-2,5-dione, CHEMBL696, .alpha.-Ethyl-.alpha.-methylsuccinimide, 3-ethyl-3-methyl-pyrrolidine-2,5-dione, DTXCID203019, Ethosuccimid, 5-21-09-00595 (Beilstein Handbook Reference), (+/-)-2-ethyl-2-methylsuccinimide, Ethylmethylsuccimide, .gamma.-Methyl-.gamma.-ethylsuccinimide, Ethosuximide [USAN:USP:INN:BAN:JAN], Etosuccimide [DCIT], Aethosuximide [German], Ethosuximidum (INN-Latin), Etosuximida (INN-Spanish), ETHOSUXIMIDE (MART.), ETHOSUXIMIDE [MART.], ETHOSUXIMIDE (USP-RS), ETHOSUXIMIDE [USP-RS], ETHOSUXIMIDE (EP MONOGRAPH), ETHOSUXIMIDE [EP MONOGRAPH], ETHOSUXIMIDE (USP MONOGRAPH), ETHOSUXIMIDE [USP MONOGRAPH], Pyknole.psi.num, Piknole.psi.n, Ethosuximide (USAN:USP:INN:BAN:JAN), Zarontin (TN), SR-01000075863, Ethosuximid, CAS-77-67-8, NCGC00016320-01, Prestwick_611, Spectrum_001385, Ethosuximide (Standard), Prestwick0_000165, Prestwick1_000165, Prestwick2_000165, Prestwick3_000165, Spectrum2_001483, Spectrum3_000944, Spectrum4_001051, Spectrum5_001073, ETHOSUXIMIDE [MI], E0746, (.+/-.)-Ethosuximide, ETHOSUXIMIDE [INN], ETHOSUXIMIDE [JAN], 2, 3-ethyl-3-methyl-, E 7138, ETHOSUXIMIDE [HSDB], ETHOSUXIMIDE [USAN], ETHOSUXIMIDE [VANDF], NCIOpen2_000014, Lopac0_000532, SCHEMBL34212, BSPBio_000029, KBioGR_001342, KBioSS_001865, DivK1c_000218, ETHOSUXIMIDE [WHO-DD], ETHOSUXIMIDE [WHO-IP], SPECTRUM1502196, 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, (+-)-, SPBio_001465, SPBio_001950, BPBio1_000033, GTPL7182, WLN: T5VMVTJ D2 D1, SCHEMBL20541518, Ethosuximide (JP18/USP/INN), Ethosuximide, analytical standard, HMS500K20, HY-B1378R, KBio1_000218, KBio2_001865, KBio2_004433, KBio2_007001, KBio3_002008, N03AD01, NINDS_000218, ETHOSUXIMIDE [ORANGE BOOK], HMS1568B11, HMS1921L14, HMS2092D20, HMS2095B11, HMS3261L05, HMS3712B11, HMS3885D12, Pharmakon1600-01502196, HY-B1378, Ethosuximide 1.0 mg/ml in Methanol, Tox21_110370, Tox21_500532, (2RS)-2-Ethyl-2-methylsuccinimide, BDBM50240424, CCG-39217, ETHOSUXIMIDUM [WHO-IP LATIN], NSC758192, s4626, AKOS005261742, Tox21_110370_1, CS-7976, DB00593, FE22867, LP00532, NSC-758192, SDCCGSBI-0050515.P004, .alpha.-Methyl-.alpha.-ethylsuccinimide, IDI1_000218, NCGC00015418-02, NCGC00015418-03, NCGC00015418-04, NCGC00015418-05, NCGC00015418-06, NCGC00015418-08, NCGC00015418-09, NCGC00015418-15, NCGC00093923-01, NCGC00093923-02, NCGC00093923-03, NCGC00093923-04, NCGC00261217-01, 3-Ethyl-3-methyl-2, 5-pyrrolidinedione, AS-16859, DA-63296, SBI-0050515.P003, 2, 5-Pyrrolidinedione, 3-ethyl-3-methyl-, AB00052288, EU-0100532, NS00010826, C07505, D00539, D70258, EN300-123801, AB00052288_04, zarontin3-Ethyl-3-methyl-pyrrolidine-2,5-dione, Q421567, SR-01000075863-1, SR-01000075863-3, SR-01000075863-5, 3-Ethyl-3-methyl-pyrrolidine-2,5-dione(Ethosuximide), BRD-A99633051-001-04-7, BRD-A99633051-001-05-4, BRD-A99633051-001-07-0, BRD-A99633051-001-08-8, 3-Ethyl-3-methyl-pyrrolidine-2,5-dione (ethosuximide), Z384975088, 3-ethyl-5-hydroxy-3-methyl-3,4-dihydro-2H-pyrrol-2-one, 4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one, 2,5-PYRROLIDINEDIONE, 3-ETHYL-3-METHYL-, (+/-)-, Ethosuximide, European Pharmacopoeia (EP) Reference Standard, Ethosuximide, United States Pharmacopeia (USP) Reference Standard, 201-048-7 |
|---|---|
| Topological Polar Surface Area | 46.2 |
| Hydrogen Bond Donor Count | 1.0 |
| Heavy Atom Count | 10.0 |
| Isotope Atom Count | 0.0 |
| Molecular Complexity | 188.0 |
| Database Name | cmaup_ingredients;npass_chem_all;pubchem |
| Defined Atom Stereocenter Count | 0.0 |
| Uniprot Id | Q9P0X4, Q6W5P4, P51450, Q96KQ7, O89049, n.a., Q9NPD5, Q9Y6L6, P15289, O95342, Q92887, O15438, O15439, P0DTD1, P10275 |
| Iupac Name | 3-ethyl-3-methylpyrrolidine-2,5-dione |
| Prediction Hob | 1.0 |
| Target Id | NPT1416 |
| Xlogp | 0.4 |
| Molecular Formula | C7H11NO2 |
| Prediction Swissadme | 0.0 |
| Inchi Key | HAPOVYFOVVWLRS-UHFFFAOYSA-N |
| Fcsp3 | 0.7142857142857143 |
| Logs | -0.896 |
| Rotatable Bond Count | 1.0 |
| Logd | 0.46 |
| Compound Name | Ethosuximide |
| Prediction Hob Swissadme | 0.0 |
| Exact Mass | 141.079 |
| Formal Charge | 0.0 |
| Monoisotopic Mass | 141.079 |
| Hydrogen Bond Acceptor Count | 2.0 |
| Molecular Weight | 141.17 |
| Covalent Unit Count | 1.0 |
| Total Atom Stereocenter Count | 1.0 |
| Total Bond Stereocenter Count | 0.0 |
| Esol | -1.0146539999999997 |
| Inchi | InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10) |
| Smiles | CCC1(CC(=O)NC1=O)C |
| Nring | 1.0 |
| Defined Bond Stereocenter Count | 0.0 |
- 1. Outgoing r'ship
FOUND_INto/from Tylophora Ovata (Plant) Rel Props:Source_db:cmaup_ingredients;npass_chem_all